Government Affairs
Refine Search
Pharmaceutical
Efforts to combat antimicrobial resistance (AMR) are gaining momentum in Europe, with the introduction of innovative measures to drive the development of new antimicrobials. 25 November 2024
Pharmaceutical
The nomination of Robert F Kennedy Jr — known as RFK Jr — for the role of US Secretary of the Department of Health and Human Services (HHS) President-elect Donald Trump sent shares in vaccine companies sharply downwards. 22 November 2024
article
The UK government has reappointed BioIndustry Association (BIA) chairman Daniel Mahony as its Life Sciences Investment Envoy. 21 November 2024
Pharmaceutical
The Danish government’s newly-unveiled health reform has been praised for tackling chronic disease care and health inequalities while driving health innovation. 18 November 2024
Pharmaceutical
New research published by the European Federation of Pharmaceutical Industries and Associations (EFPIA) provides in-depth analysis of the economic footprint of the pharmaceutical industry in Europe, across member states and compares Europe to other regions of the world. 18 November 2024
Pharmaceutical
Johnson & Johnson has taken legal action to defend a contentious rebate initiative, filing a lawsuit in the US District Court for the District of Columbia. 15 November 2024
Pharmaceutical
The share prices of Pfizer, GSK, Novavax and other vaccine companies were all markedly lower on Friday. This was not due to the publication of disappointing research results in the sphere, or an ominous stance taken by a major regulator on a key filing, but rather a political development that could spell trouble for the vaccines field as a whole. 15 November 2024
Biotechnology
BeiGene has announced plans to rebrand as BeOne Medicines, a move the cancer specialist says reflects its commitment to fighting cancer through collaboration. 15 November 2024
Pharmaceutical
Danish patients are being offered fewer innovative treatments than Norwegians and Swedes, a new estimate from the Danish Medicines Council shows. 11 November 2024
Pharmaceutical
According to the Swedish pharma trade group Lif, it is positive that, in the updated life science strategy, the government expresses an ambition for Sweden to become more attractive for research investments. 11 November 2024
Pharmaceutical
Li Li, Commissioner of China's National Medical Products Administration (NMPA), and Mette Aaboe Hansen, interim director general of Danish Medicines Agency, have signed a letter of intent to promote bilateral cooperation in regulation of drugs and medical devices. 11 November 2024
Pharmaceutical
Following the news that Donald Trump is the winner of the 2024 US Presidential Election, Morningstar Equity analyst Julie Utterback has published a new note about the impact of this on the managed-care industry. 7 November 2024
Pharmaceutical
UK pharma major AstraZeneca, which has invested heavily in China, hosted a sell-side analyst call on Wednesday (November 6) to discuss the recent media reports about ongoing investigations in China. 7 November 2024
Pharmaceutical
Some of the UK’s leading academics and industry professionals have welcomed Chancellor Rachel Reeves’ £520 million ($669 million) pledge to develop the country’s medicine manufacturing capabilities. 6 November 2024
Pharmaceutical
European regulators will decide by December 6 whether Novo Holdings, the controlling shareholder of Danish pharma giant Novo Nordisk, can finalize its $16.5 billion acquisition of contract drug manufacturer Catalent. 5 November 2024
Pharmaceutical
The Danish government is rolling out the red carpet and welcomes several pharmaceutical companies. 4 November 2024
Generics
Medicines for Europe has launched a study of market barriers faced by European generics and biosimilar pharmaceutical companies operating in 11 key third-country markets. 31 October 2024
Pharmaceutical
Following the first Labour budget for 14 years, the Association of the British Pharmaceutical Industry (ABPI) welcomes Chancellor Rachel Reeves’ measures to improve UK life sciences competitiveness. 30 October 2024
Pharmaceutical
HOPO Therapeutics has been awarded a contract valued at up to $226 million from the Biomedical Advanced Research and Development Authority (BARDA). 29 October 2024
Pharmaceutical
The Danish government has presented part of the plan for a future life science strategy, which has been welcomed by the industry. 28 October 2024
Pharmaceutical
US Senators Chris Coons (Democrat, Delaware) and Dick Durbin (Democrat, Illinois), members of the Senate Judiciary Committee, and Mazie Hirono (Democrat, Hawaii), member of the Senate Committee on Small Business and Entrepreneurship, have introduced legislation to strengthen America’s patent system and target abusers. 4 March 2015
Pharmaceutical
The proposed bonus for Olivier Brandicourt, the new chief executive of Sanofi has drawn criticism from government and trade unions. 25 February 2015
Pharmaceutical
The European Federation of Pharmaceutical Industries and Associations (EFPIA) has welcomed the debate held in the European parliament last week. 23 February 2015
Pharmaceutical
The Union Finance Minister should take his government’s “Make in India” campaign to the next level by taking steps to boost indigenous research, says Pawan Chaudhary, chairman and managing director of Indian research-based drugmaker Venus Remedies, outlining his expectations from the 2015-16 Union Budget. 19 February 2015
Biotechnology
The passage of unwelcome legislation last week to cap claims on the Australian Research and Development (R&D) Tax incentive and its retrospective application to July 1, 2014, has prompted calls for the government to provide transitional arrangements for biotech companies abandoned in a difficult position, according to trade group AusBiotech. 17 February 2015
Generics
The Russian government plans to provide subsidies for the production of pharmaceutical substances for leading national drugmakers this year, according to Alexander Petrov, member of the Committee on Health of the Russian State Duma. 16 February 2015
Biotechnology
The Australian government’s shock deal with the Palmer United Party and Independent Senator Xenophon to pass legislation in the Senate on Tuesday night to limit the Research and Development (R&D) Tax Incentive deals a further blow to Australia’s innovation ecosystem and will impact large and small biotech companies, the country’s trade body AusBiotech has warned. 12 February 2015
Generics
The Russian government may consider the possibility of the re-purchase of the Russian pharmaceutical producer Veropharm that was recently acquired by the US drugmaker Abbott. 9 February 2015
Pharmaceutical
Ukraine’s Association of Pharmaceutical Research and Development (APRaD) in cooperation with the American Chamber of Commerce in Ukraine has appealed to the Minister of Health of Ukraine, Minister of Economic Development and Trade of Ukraine and the head of the VR Health Care Committee about the introduction of additional 5%VAT on imported medicines and its influence on public procurement. 9 February 2015
Pharmaceutical
Drug prices in Russia may increase by 20% this year, according to a recent statement of Russia’s Prime Minister Dmitry Medvedev during his visit to Ufa. 9 February 2015
Pharmaceutical
In a written response to the Danish Parliamentary Health Committee, Minister of Health Nick Hækkerup emphasises that the price-cap agreement made with Denmark’s pharma trade group LIF for the hospital sector is working as intended to provide stable prices. 9 February 2015
Generics
Stiff competition from China is undermining the Indian bulk drug industry. While imports from China are growing at over 30%, Indian exporters maintain that it is difficult to crack the Chinese market, reports The Pharma Letter’s India correspondent. 8 February 2015
Pharmaceutical
The Intergenerational Reports on aging from the Australian government have seriously overestimated Pharmaceutical Benefit Scheme expenditure as a proportion of GDP, according to trade group Medicines Australia. 4 February 2015
Pharmaceutical
The Obama Administration wants to win the authority to negotiate over the prices of specialty drugs for recipients of Medicare, the federal government program that providers health coverage to the elderly, according to US media reports. 3 February 2015
Pharmaceutical
The promised January 2015 release of a discussion draft of legislation to implement the 21st Century Cures Initiative, which was launched in April 2014 by now-Chairman of the House Energy and Commerce Committee Representative Fred Upton (Republican, Michigan) and Committee Member Representative Diana DeGette (Democrat, Colorado), has now been posted on the Committee website stating: “21st Century Cures Legislative Phase Now Underway.” 28 January 2015
Pharmaceutical
This January 26, India's Republic Day is set to be a momentous one with the country hosting the US President Barack Obama as the chief guest for the parade, reports The Pharma Letter’s India correspondent. 23 January 2015
Biotechnology
In his State of the Union speech to the American public this week, US President Barak Obama said that the White House is launching the Precision Medicine Initiative, to invest resources into medical research and technology, but provided little elaboration. 22 January 2015
Pharmaceutical
Prices for vital and essential drugs will not be a subject of currency fluctuations, according to recent statements by Russian Minister of Health Veronika Skvortsova. 18 January 2015
Pharmaceutical
The UK’s National Audit Office has published a report, Progress in improving cancer services and outcomes in England, which confirms that English cancer patients’ health outcomes and survival rates are poorer than their European counterparts due to access to life-saving medicines. 16 January 2015
Pharmaceutical
Ukraine is on the verge of a new increase of pharmaceutical prices and a potential shortage of drugs, due to recently announced state plans to introduce an additional charge on drug imports to the country in the amount of 5%-10%. 13 January 2015
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze